NVDA vs UNH: Which Is the Better Buy?

Side-by-side comparison of NVIDIA Corporation and UnitedHealth Group Incorporated β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-17.
NVIDIA Corporation Β· Technology
$210.69
+45.0% upside to fair value
Grade B High Quality
VS
UnitedHealth Group Incorporated Β· Healthcare
$423.38
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
UNH trades at a lower forward P/E (27.2x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric NVDA UNH
Current Price $210.69 $423.38
Fair Value Estimate $305.50 $613.90
Upside to Fair Value +45.0% +45.0%
Market Cap $5,103.1B $384.5B
Forward P/E 32.1x 27.2x
EV / EBITDA 26.5x 13.8x
Price / Sales 20.1x 0.8x
Price / FCF 42.9x 19.6x
Revenue Growth YoY +85.2% +0.4%
Gross Margin 74.1% 18.8%
Operating Margin 64.0% 4.2%
Return on Equity 111.7% 12.4%
Dividend Yield 0% 0%
FCF Yield 2.33% 5.12%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
NVDA β€” NVIDIA Corporation
NVIDIA Corporation is a leading technology company specializing in semiconductors, particularly GPUs and AI accelerators, with a dominant market position in AI training markets holding over 80% share. The company exhibits exceptional business quality with a founder-led management team boasting over 30 years of continuous leadership, very high profitability with gross margins above 74% and net mar…
UNH β€” UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates in the healthcare sector, specifically within medical and healthcare plans, providing a durable business model supported by a strong competitive moat and consistent earnings growth. The company currently trades at a price of $423.38 with a market cap of $359.873 billion, reflecting a valuation that is cheap relative to its five-year history, supported by a…
Accumulation Zones
Metric NVDA UNH
Zone Low $229.12 $460.42
Zone High $259.68 $521.81
In Buy Zone? Yes Yes
← NVDA Research    UNH Research β†’    All Research